# Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

> **NCT07141732** · PHASE1 · RECRUITING · sponsor: **Joint Stock Company European Medical Centre** · enrollment: 15 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** Resection of newly diagnosed glioblastoma combined with intraoperative balloon electronic brachytherapy using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System

## Key facts

- **NCT ID:** NCT07141732
- **Lead sponsor:** Joint Stock Company European Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141732, "Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07141732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*